Klow 80mg

KLOW 80mg is a combined research material containing four individually characterised compounds: GHK-Cu, KPV, BPC-157 and TB-500. It is supplied as a laboratory reference material for research where investigators want to examine multiple peptide-associated signalling pathways within a single formulation.

The constituent compounds have different molecular identities and research histories. GHK-Cu is a copper-binding tripeptide; KPV is a short tripeptide derived from the C-terminal sequence of α-MSH; BPC-157 is a 15-amino-acid synthetic peptide; and TB-500 corresponds to a functional region of Thymosin Beta-4. Because the blend combines different compounds, experimental interpretation should distinguish the contribution of the individual constituents where the study design requires mechanistic attribution.

KLOW is therefore best documented as a combined reference material rather than treating it as a single naturally occurring peptide. Researchers should record the product identity, batch information and formulation details in experimental documentation.

Each batch is supplied with a Certificate of Analysis (COA) from independent third-party testing, covering HPLC purity and mass-spectrometry identity. Researchers should review the applicable documentation for the exact KLOW batch before use and follow their laboratory's storage and handling requirements.

KLOW 80mg is for laboratory research use only. It is not a medicinal product, is not licensed by the MHRA and is not intended for human or veterinary use, diagnosis, treatment or self-administration. Sold only to qualified researchers aged 18 or over.